Last updated: August 17, 2026

Chronic kidney disease (CKD) is a major global health concern, affecting millions worldwide. Infection-induced CKD, a subset of CKD, arises from infections that damage the kidneys, leading to progressive loss of function. Despite advancements in conventional therapies, the treatment options for infection-induced CKD remain limited. Stem cell therapy has emerged as a promising approach to address this unmet medical need, offering the potential to regenerate damaged kidney tissue and restore function.

Infection-Induced Chronic Kidney Disease: An Overview

Infection-induced CKD can result from various infections, including urinary tract infections, pyelonephritis, and sepsis. These infections trigger an inflammatory response within the kidneys, leading to tissue damage and scarring. The progressive accumulation of scar tissue impairs kidney function, ultimately progressing to end-stage renal disease (ESRD) if left untreated.

Causes and Pathogenesis of Infection-Induced CKD

Urinary tract infections (UTIs) are the most common cause of infection-induced CKD. Bacteria, such as Escherichia coli, ascend the urethra and invade the bladder, causing inflammation and damage to the renal parenchyma. Pyelonephritis, an infection of the kidney itself, can also lead to CKD if left untreated. Sepsis, a severe systemic infection, can also cause kidney damage as part of its widespread inflammatory response.

Scientific case review

Scientific Case Review

Would you like to understand whether current clinical programs, recent research developments, or emerging approaches may be relevant to your individual situation?

Share your question with our scientific research team and receive information focused on the areas of current research that may be relevant to your case.

  • Review of the information you provide
  • Relevant research and clinical program information
  • A clear response focused on your situation
What happens next? Send your question, receive a focused scientific review, and get a clear response about research and clinical programs relevant to your situation.
Your scientific review will be prepared by Dr. Helen Melnik, PhD , who has more than 25 years of experience in stem cell research and international clinical programs.

No obligation. Your question will be reviewed confidentially.

Educational and research information only. This service does not constitute medical advice, diagnosis, prescription, or a personalized treatment recommendation.

WhatsApp